Back

Effectiveness and safety of apixaban versus warfarin among high-risk subgroups of non-valvular atrial fibrillation patients: a propensity score matched analysis

28 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Stroke prevention Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Xiaoyan Li

Princeton (United States of America)

53 More presentations in this session

Presentation thumbnail
Doctor A. Tyminska (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Doctor M. Gupta (Toronto, CA)
Abstract
Presentation thumbnail
Professor H. Bonnemeier (Luebeck, DE)
Abstract Slides
Presentation thumbnail
Ms D. Loikas (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Doctor J. Franchino-Elder (Ridgefield, US)
Abstract

Access the full session

Session thumbnail
Poster session 4 - Stroke prevention

The Event

Event poster

ESC Congress 2017

28 August 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources